-
Chinese (Simplified)
-
English
-
German
-
Korean
-
Spanish
Chinese (Simplified)
English
German
Korean
Spanish
Sign up for an account to enjoy easy online shopping and instant order tracking.
The antibody against YARS was raised in rabbit using the Recombinant Human Tyrosine--tRNA ligase, cytoplasmic protein (2-528AA) as the immunogen. This antibody exists as a non-conjugated isotype IgG, purified by protein G with a purity greater than 95%. This antibody has been validated on ELISA, WB, IHC, IF.
The antibody against YARS was raised in rabbit using the Recombinant Human Tyrosine–tRNA ligase, cytoplasmic protein (2-528AA) as the immunogen. This antibody exists as a non-conjugated isotype IgG, purified by protein G with a purity greater than 95%. This antibody has been validated on ELISA, WB, IHC, IF.
$299.00
| Cat.No | ADC-50939A | Clonality | Polyclonal |
|---|---|---|---|
| Host Species | Rabbit | Target Name | YARS |
| Target Synonyms | CMTDIC antibody; SYYC_HUMAN antibody; Tyrosine tRNA ligase, cytoplasmic antibody; Tyrosine tRNA ligase 1, cytoplasmic antibody; Tyrosyl tRNA synthetase antibody; Tyrosyl--tRNA ligase antibody; Tyrosyl-tRNA synthetase, cytoplasmic antibody; TyrRS antibody; yars antibody; YRS antibody; YTS antibody | Form | Liquid |
| Species Reactivity | Human | Isotype | IgG |
| Storage Buffer | 0.01M PBS, 0.03% Proclin 300; Constituents: 50% Glycerol, PH 7.4 | Purification Method | >95%, Protein G purified |
| Conjugate | Non-conjugated | Application | ELISA, IF, IHC, WB |
| Storage | Upon receipt |
| Immunogen Description | Recombinant Human Tyrosine--tRNA ligase, cytoplasmic protein (2-528AA) | Target Species | Human |
|---|---|---|---|
| Immunogen Sequence | Complete sequences for the immunogen, target protein, and peptides are available upon request. | Uniprot ID | P54577 |
Uniprot Id
P54577
Target Species
Human
Target Name
YARS
Target Full Name
Tyrosine--tRNA ligase, cytoplasmic
Target Function
Catalyzes the attachment of tyrosine to tRNA(Tyr) in a two-step reaction: tyrosine is first activated by ATP to form Tyr-AMP and then transferred to the acceptor end of tRNA(Tyr).
Target Involvement
Charcot-Marie-Tooth disease, dominant, intermediate type, C (CMTDIC)
Target Subcellular Location
Cytoplasm.
Target Protein Families
Class-I aminoacyl-tRNA synthetase family
Target Research Area
Metabolism
Target Synonyms
CMTDIC; SYYC_HUMAN; Tyrosine tRNA ligase, cytoplasmic; Tyrosine tRNA ligase 1, cytoplasmic; Tyrosyl tRNA synthetase; Tyrosyl--tRNA ligase; Tyrosyl-tRNA synthetase, cytoplasmic; TyrRS; yars; YRS; YTS
Target Background
Aminoacyl-tRNA synthetases catalyze the aminoacylation of tRNA by their cognate amino acid. Because of their central role in linking amino acids with nucleotide triplets contained in tRNAs, aminoacyl-tRNA synthetases are thought to be among the first proteins that appeared in evolution. Tyrosyl-tRNA synthetase belongs to the class I tRNA synthetase family. Cytokine activities have also been observed for the human tyrosyl-tRNA synthetase, after it is split into two parts, an N-terminal fragment that harbors the catalytic site and a C-terminal fragment found only in the mammalian enzyme. The N-terminal fragment is an interleukin-8-like cytokine, whereas the released C-terminal fragment is an EMAP II-like cytokine.
Notification